DanioLabs Snares 3.2M in VC Funding; Hopes to Take Drug-Discovery Business to Next Level | GenomeWeb

DanioLabs, a Cambridge, UK-based drug-discovery firm, said last week that it has closed its first institutional financing round, raising a total of £3.2 million ($6 million).

The financing round was led by Cambridge Gateway Fund, and supported by other institutional investors including Merifin and NVM. In addition, a number of existing and new angel investors contributed to the fundraising, DanioLabs said.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

A startup wants to match customers to wine based on their DNA and one critic calls the idea 'silly,' Stat News reports.

Researchers trace the origins of brown rats using genetic analysis to China, the New York Times reports.

In Science this week: gene flow between ancient chimpanzees and bonobos, and more.

In Nature this week: genetic history of HIV in the US, and more.